ArticleCureus2025
An Unusual Presentation of Antiphospholipid Syndrome With Seizures and Sagittal Sinus Thrombosis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral venous sinus thrombosis (CVST) is a rare but potentially life-threatening form of stroke. It may present with nonspecific neurological symptoms, including headache, seizures, or focal deficits. One of the rare but important underlying causes is antiphospholipid syndrome (APS), an autoimmune prothrombotic condition associated with persistent antiphospholipid antibodies: lupus anticoagulant (LA), anticardiolipin (aCL), or anti-β2 glycoprotein I (anti-β2GPI). APS-related CVST is typically seen in young women, often with systemic autoimmune disease such as systemic lupus erythematosus. We present a rare and atypical case of a 55-year-old man with no prior autoimmune history who developed new-onset seizures and right-sided weakness while visiting the UK. Imaging revealed a haemorrhagic infarct in the left frontal lobe secondary to superior sagittal sinus thrombosis. Initial thrombophilia screening identified an isolated positive lupus anticoagulant, with confirmatory repeat testing at 12 weeks fulfilling the revised Sapporo criteria for APS. The patient was managed with anticoagulation, antiepileptics, and specialist follow-up. This case is unusual due to several factors: the patient's demographic (middle-aged male), the absence of systemic autoimmune disease, presentation with seizures and intracerebral haemorrhage, and the isolated lupus anticoagulant positivity without triple antibody presence. It highlights the importance of considering APS in unprovoked CVST even in the absence of classic risk factors. Early diagnosis, appropriate imaging, and timely anticoagulation can improve outcomes. This case reinforces the need for autoimmune and thrombophilia screening in atypical stroke presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.